{"schema_version":"1","generated_at":"2026-11-18T04:07:57.566Z","data_as_of":null,"url":"https://www.findmykol.com/kol/aya-haggiagi","json_url":"https://www.findmykol.com/kol/aya-haggiagi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"aya-haggiagi","name":"Aya Haggiagi","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"NewYork–Presbyterian Hospital","institution_url":"https://www.findmykol.com/institution/weill-cornell-medicine","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1366716300","orcid":"0000-0002-8101-8901","openalex":"A5050534702"},"summary":"Aya Haggiagi is a Neurology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 43 publications with 511 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":43,"cited_by_count":511,"h_index":10,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Jazz Pharmaceuticals","program_year":2025,"amount_usd":189092.09,"payment_count":17,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366716300"},{"payer":"Pfizer","program_year":2025,"amount_usd":160887.82,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366716300"},{"payer":"Telix Pharmaceuticals","program_year":2023,"amount_usd":118.93,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1366716300"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1366716300","source":"payments"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Nervous system","share_pct":53.8,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":53.8,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":46.2,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":46.2,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2022,"office_pct":92.3,"facility_pct":7.7},"source":"medicare"},"publications":{"total":43,"shown":5,"withheld":38,"matched_by":"OpenAlex author record","recent":[{"title":"Diffuse Midline Gliomas: Clinical, Diagnostic, and Therapeutic Perspectives","year":2026,"journal":"Biomedicines","source_url":"https://doi.org/10.3390/biomedicines14040934","status":"verified"},{"title":"The Elusive Origin of Glioblastoma: Where Do We Stand?","year":2026,"journal":"Cells","source_url":"https://doi.org/10.3390/cells15070590","status":"verified"},{"title":"Phase 1b study of a brain-penetrant MEK inhibitor, PF-07799544, plus next-generation BRAF dimer inhibitor, PF-07799933, in advanced BRAF -mutant melanoma.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.9512","status":"verified"},{"title":"Clinical Utility of [ 18 F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma","year":2025,"journal":"American Journal of Neuroradiology","source_url":"https://doi.org/10.3174/ajnr.a9120","status":"verified"},{"title":"RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf165","status":"verified"}],"source":"works"},"similar":[{"name":"Melana Yuzefpolskaya","slug":"melana-yuzefpolskaya","institution":"NewYork–Presbyterian Hospital","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/melana-yuzefpolskaya","json_url":"https://www.findmykol.com/kol/melana-yuzefpolskaya/profile.json"},{"name":"Kevin Clerkin","slug":"kevin-clerkin","institution":"NewYork–Presbyterian Hospital","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/kevin-clerkin","json_url":"https://www.findmykol.com/kol/kevin-clerkin/profile.json"},{"name":"Brandon Swed","slug":"brandon-swed","institution":"NewYork–Presbyterian Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brandon-swed","json_url":"https://www.findmykol.com/kol/brandon-swed/profile.json"},{"name":"Lawrence Lenke","slug":"lawrence-lenke","institution":"NewYork–Presbyterian Hospital","specialty":"Orthopaedic Surgery","url":"https://www.findmykol.com/kol/lawrence-lenke","json_url":"https://www.findmykol.com/kol/lawrence-lenke/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"David Knopman","slug":"david-knopman","institution":"Mayo Clinic Rochester","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-knopman","json_url":"https://www.findmykol.com/kol/david-knopman/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":38}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}